Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC)

Completed

Conditions studied: Ulcerative Colitis

In brief

The purpose of this protocol is: 1. To quantify the prevalence of adherence to topical mesalamine in patients with UC 2. To describe the determinants of medication adherence in patients with UC prescribed topical mesalamine

Key facts

Study ID

NCT01678300

Run by

Beth Israel Deaconess Medical Center

People needed

70

Starts

2012-08-01

Expected to finish

2015-11-01

Last updated by the study team

2015-11-16

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• must have ulcerative colitis diagnosed by a doctor at least 1 month prior to study participation
• must be prescribed topical mesalamine (e.g. Rowasa enemas or Canasa suppositories) by a doctor
• must be receiving care at Beth Israel Deaconess Medical Center

You may not qualify if…

• no diagnosis of ulcerative colitis
• no prescription for topical mesalamine
• not receiving care at Beth Israel Deaconess Medical Center

Where it is running

• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.